Bone Graft
-
Biologics
Artoss Announces NanoBone® QD Bone Graft
Press Release/October 23, 2017 Artoss, Inc. is pleased to announce NanoBone QD Bone Graft. Paul Byerley, Managing Director of Artoss,…
Read More » -
Hospitals
Amedica Submits 24-Month Clinical Data to FDA for Clearance of Composite Interbody Spinal Device
SALT LAKE CITY, November 10, 2015 – Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform,…
Read More » -
Hospitals
Cerapedics Receives FDA Approval for i-FACTOR™ Peptide Enhanced Bone Graft in Cervical Spine Surgery
WESTMINSTER, Colo., Nov. 3, 2015 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved…
Read More » -
Biologics
Biodegradable polymer could help heal the bones of patients with orthopedic injuries
A plastic derived from cornstarch combined with a volcanic ash compound, Montmorillonite clay, could help heal the bones of hundreds…
Read More » -
Hospitals
Wright Medical’s bone graft receives FDA approval: 5 observations
By Anuja Vaidya Wright Medical’s Augment Bone Graft product received FDA approval. Here are five observations: 1. The product is an alternative…
Read More » -
Biologics
BIOMATLANTE Obtains CE Approval to Market EZ Cure Plug and Strip
BIOMATLANTE (Vigneux de Bretagne), a medical device company specialized in bone regeneration, today announced the CE regulatory approval of EZ…
Read More » -
Biologics
Cerapedics uses silk from a moth to create new spine bone graft
Biloine W. Young • Thu, February 5th, 2015 Cerapedics, Inc., a privately-held orthobiologics company located in Westminster, Colorado, has received…
Read More » -
Biologics
Wright Medical (WMGI) Reports FDA Approvable of Augment Bone Graft, Lowers FY14 Sales Guidance
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that its BioMimetic subsidiary has received an Approvable Letter from the U.S.…
Read More » -
Recon
‘Shocked’ Wright CEO Plans Appeal on Augment ‘Not Approvable’ Letter
Wright Medical said it will appeal the FDA’s decision not to approve the Augment bone graft as an alternative to…
Read More » -
FDA approval of BioMimetic’s Augment Bone Graft dependent on more information
In a post-panel response letter, the FDA told BioMimetic Therapeutics Inc. that it would need to submit more information about…
Read More » -
NovaBone Announces New Moldable Bone Graft
JACKSONVILLE, Fla.–(BUSINESS WIRE)–NovaBone Products announces the introduction of MacroPor-Si+ to its portfolio of biologically active bone graft substitutes. NovaBone Products develops…
Read More » -
Cerapedics announces i-FACTOR biologic bone graft study results in PLIF spine surgery
Cerapedics, Inc., a medical device company focused on developing and commercializing novel osteobiologic products, announced the results of a prospective,…
Read More » -
BioMimetic Therapeutics, Inc. Initiates Augment™ Rotator Cuff Graft Trial
FRANKLIN, Tenn.–(BUSINESS WIRE)–BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced it initiated enrollment in a pilot clinical trial to assess the…
Read More » -
Orthovita Receives FDA Clearance for Vitoss™ Bioactive Foam-2X Bone Graft Substitute
MALVERN, Pa.–(BUSINESS WIRE)–Orthovita, Inc. (NASDAQ: VITA), an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the…
Read More » -
BioMimetic Therapeutics Receives Filing Letter from FDA for Augment™ Bone Graft PMA
FRANKLIN, Tenn.–(BUSINESS WIRE)–BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced the Food & Drug Administration (FDA) has accepted for review its…
Read More »